2024³â ´ëÇѳ»ºÐºñÇÐȸ ´ëÇѼºÈ£¸£¸ó¿¬±¸È¸ ½ÉÆ÷Áö¾ö : 2024-08-24
±³À°ÀÏÀÚ : 2024-08-24
±³À°Àå¼Ò : ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï Æĸ£³ª½º 2Ãþ ¾ÆÀ̸®½ºÈ¦
±³À°ÁÖÁ¦ : 2024³â ´ëÇѳ»ºÐºñÇÐȸ ´ëÇѼºÈ£¸£¸ó¿¬±¸È¸ ½ÉÆ÷Áö¾ö
ÁÖÃÖ±â°ü : ´ëÇѳ»ºÐºñÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ³²¼ºÈ£¸£¸ó¿¬±¸È¸
´ã´çÀÚ : ±èŹÎ
¿¬¶ôó : 031-442-2114
À̸ÞÀÏ : pnbbio@pnbbio.com
±³À°Á¾·ù : ³»°ú, »êºÎÀΰú, ºñ´¢ÀÇÇаú, °¡Á¤ÀÇÇаú
Âü¼®¿¹»óÀÎ : 100¸í
Èñ¸ÁÆòÁ¡ : 4Á¡
Áö¿ª : ¼¿ïƯº°½Ã
±³À°½Ã°£ : 4 ½Ã°£ 55ºÐ
¼¼ºÎ¼ö°·á : 20,000¿ø
ºñ°í Àü¹®ÀÇ, ÀϹÝÀÇ:20,0000¼ö·ÃÀÇ,°£È£»ç,¿¬±¸¿ø,±âÃÊ°úÇÐÀÚ: 10,000´ëÇпø»ý, Çлý: ¹«·á
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 08¿ù 24ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï Æĸ£³ª½º 2F ¾ÆÀ̸®½ºÈ¦ 09:00~09:25 Overall aspect of menopausal hormone therapy in Korea Àü¼º¿í(ÀÎÁ¦ÀÇ´ë ÇØ¿î´ë¹éº´¿ø »êºÎÀΰú)
±³À°½Ã°£ 08¿ù 24ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï Æĸ£³ª½º 2F ¾ÆÀ̸®½ºÈ¦ 09:25~09:50 Menopausal hormone therapy: Window of opportunity ¹ÚÁÖÇö (¿¬¼¼ÀÇ´ë ¿ëÀμ¼ºê¶õ½ºº´¿ø »êºÎÀΰú)
±³À°½Ã°£ 08¿ù 24ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï Æĸ£³ª½º 2F ¾ÆÀ̸®½ºÈ¦ 09:50~10:15 Concerns regarding menopausal hormone therapy ±è°æ¿í(µ¿ÅºÁ¦ÀϺ´¿ø ³»ºÐºñ³»°ú)
Åä·Ð 08¿ù 24ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï Æĸ£³ª½º 2F ¾ÆÀ̸®½ºÈ¦ 10:15~10:30 Discussion ()
ÈÞ½Ä 08¿ù 24ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï Æĸ£³ª½º 2F ¾ÆÀ̸®½ºÈ¦ 10:30~10:40 Coffee break ()
±³À°½Ã°£ 08¿ù 24ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï Æĸ£³ª½º 2F ¾ÆÀ̸®½ºÈ¦ 10:40~11:05 Women's perspectives Ȳ±Ô¸® (¼¿ïÀÇ´ë ¼¿ï´ëº´¿ø »êºÎÀΰú)
±³À°½Ã°£ 08¿ù 24ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï Æĸ£³ª½º 2F ¾ÆÀ̸®½ºÈ¦ 11:05~11:30 Men¡¯s perspectives ±èŹü(°¡ÃµÀÇ´ë ±æº´¿ø ºñ´¢ÀÇÇаú)
±³À°½Ã°£ 08¿ù 24ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï Æĸ£³ª½º 2F ¾ÆÀ̸®½ºÈ¦ 11:30~11:55 PCOS: an endocrinological insight into assessment and management ±èÁøÁÖ (¼¿ïÀÇ´ë ¼¿ï´ëº´¿ø »êºÎÀΰú)
Åä·Ð 08¿ù 24ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï Æĸ£³ª½º 2F ¾ÆÀ̸®½ºÈ¦ 11:55~12:10 Discussion ()
±³À°½Ã°£ 08¿ù 24ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï Æĸ£³ª½º 2F ¾ÆÀ̸®½ºÈ¦ 12:10~12:35 Effects of testosterone replacement therapy on prevention and treatment of diabetes (results from T4DM and TRANSVERSE trials) ±è°æ¹Î (¿¬¼¼ÀÇ´ë ¿ëÀμ¼ºê¶õ½ºº´¿ø ³»ºÐºñ³»°ú)
±³À°½Ã°£ 08¿ù 24ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï Æĸ£³ª½º 2F ¾ÆÀ̸®½ºÈ¦ 13:20~13:45 Functional hypogonadism ±è¿µ»ó (Â÷ÀÇ´ë ºÐ´çÂ÷º´¿ø °¡Á¤ÀÇÇаú )
±³À°½Ã°£ 08¿ù 24ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï Æĸ£³ª½º 2F ¾ÆÀ̸®½ºÈ¦ 13:45~14:10 Metabolic roles of TRT ÃÖ¿ëÁØ (¾ÆÁÖÀÇ´ë ¾ÆÁִ뺴¿ø ³»ºÐºñ³»°ú)
±³À°½Ã°£ 08¿ù 24ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï Æĸ£³ª½º 2F ¾ÆÀ̸®½ºÈ¦ 14:10~14:35 General development process ¾È¼øÅÂ(°í·ÁÀÇ´ë °í·Á´ë¾È¾Ïº´¿ø ºñ´¢ÀÇÇаú)
Åä·Ð 08¿ù 24ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï Æĸ£³ª½º 2F ¾ÆÀ̸®½ºÈ¦ 14:35~14:50 Discussion ()